Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis.
Compounds that cause peroxisome proliferation in rats and mice have been reported to interfere with mitochondrial (mt) bioenergetics and possibly biogenesis. The purpose of this investigation was to establish whether proliferation of peroxisomes and mitochondria are necessarily related. Perfluorooctanesulfonate (PFOS) and N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE) were investigated as peroxisome proliferators in comparison to perfluorooctanoic acid (PFOA). Three parameters were chosen to assess peroxisome proliferation, stimulation of lauroyl CoA oxidase activity, reduction of serum cholesterol concentration, and hepatomegaly. mt Biogenesis was assessed through cytochrome oxidase activity, cytochrome content and mitochondrial DNA (mtDNA) copy number. PFOA, PFOS, or N-EtFOSE was administered via a single i.p. injection at 100 mg/kg in male rats, and measurements were made 3 days later. In this model, PFOS and PFOA share similar potencies as peroxisome proliferators, whereas N-EtFOSE showed no activity. mt Endpoints were altered only in the PFOA treatment group, which consisted of a decrease cytochrome oxidase activity in liver tissue and an increase in the mtDNA copy number. None of the perfluorooctanoates significantly altered mt cytochrome content following acute in vivo treatment. These data demonstrate that acute administration of PFOS or PFOA causes hepatic peroxisome proliferation in rats. However, stimulation of mt biogenesis is not a characteristic response of all peroxisome proliferators.
Berthiaume
Jessica
J
Department of Biochemistry and Molecular Biology, Toxicology Graduate Program, University of Minnesota School of Medicine, 10 University Drive, Duluth, MN 55812-2496, USA.
Wallace
Kendall B
KB
D042964:Acyl-CoA Dehydrogenase; D017738:Alkanesulfonic Acids / Q000633:toxicity*; D000818:Animals; D002210:Caprylates / Q000633:toxicity*; D003576:Electron Transport Complex IV / Q000378:metabolism; D044943:Fatty Acid Desaturases / Q000378:metabolism; D005466:Fluorocarbons / Q000633:toxicity*; D006845:Hydrocarbons, Fluorinated; D008297:Male; D008830:Microbodies / Q000187:drug effects*; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000502:physiology; D020025:Peroxisome Proliferators / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013449:Sulfonamides / Q000633:toxicity*; D015431:Weight Loss / Q000187:drug effects
C435127:2-(N-ethylperfluorooctanesulfonamido)ethyl alcohol; D017738:Alkanesulfonic Acids; D002210:Caprylates; D005466:Fluorocarbons; D006845:Hydrocarbons, Fluorinated; D020025:Peroxisome Proliferators; D013449:Sulfonamides; C023036:perfluorooctanoic acid; C076994:perfluorooctane sulfonic acid; D044943:Fatty Acid Desaturases; D042964:Acyl-CoA Dehydrogenase; D003576:Electron Transport Complex IV